Literature DB >> 24280093

Endemic hepatitis E in the Czech Republic.

Pavel Chalupa1, Petra Vasickova, Ivo Pavlik, Michal Holub.   

Abstract

BACKGROUND: An increasing incidence of endemic hepatitis E (HE) has been reported in developed countries. Thus, an evaluation of the clinical characteristics of the disease and the utility of the current diagnostic methods is warranted.
METHODS: Fifty-one adult acute patients with HE hospitalized in a single center between the years 2009 and 2012 were evaluated. Serological and molecular techniques (detection of hepatitis E virus [HEV] RNA from stool and serum samples by quantitative reverse transcription polymerase chain reaction) with sequencing and phylogenetic analysis were used for diagnosis, and the clinical, laboratory, and epidemiological parameters of the patients were evaluated.
RESULTS: Forty-nine (96.1%) patients had acute endemic HE and 2 (3.9%) had an imported infection. In the cohort of patients with acute symptomatic HE (n = 47), men outnumbered women (40:7), the patients were in older middle age (mean, 60.57 years), and they had elevated median values of total bilirubin (6.67 mg/dL), alanine aminotransferase (2288.82 U/L), aspartate aminotransferase (1251.76 U/L), gamma-glutamyl transferase (360.53 U/L), and alkaline phosphatase (197.06 U/L). Serology was positive in 50 (98%) of the patients, and 1 case was diagnosed by polymerase chain reaction only. HEV RNA was detected in at least 1 specimen from 84.3% of the patients, and 28 of 29 tested isolates belonged to genotype 3. The eating of meat, innards, other home-prepared pork products, or the tasting of raw meat before cooking were the most frequently reported data (reported by 25 patients [49.0%]).
CONCLUSIONS: Large numbers of the endemic cases of HE were caused by HEV genotype 3, and the clinical characteristics of endemic HE were demonstrated.

Entities:  

Keywords:  clinical findings; endemic cases; hepatitis E; zoonosis

Mesh:

Substances:

Year:  2013        PMID: 24280093     DOI: 10.1093/cid/cit782

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

1.  Hepatitis E in Israel: A nation-wide retrospective study.

Authors:  Ortal Erez-Granat; Tamar Lachish; Nili Daudi; Daniel Shouval; Eli Schwartz
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

Review 2.  Hiding in Plain Sight? It's Time to Investigate Other Possible Transmission Routes for Hepatitis E Virus (HEV) in Developed Countries.

Authors:  Nicola J King; Joanne Hewitt; Anne-Marie Perchec-Merien
Journal:  Food Environ Virol       Date:  2018-04-05       Impact factor: 2.778

3.  Disparities in detection of antibodies against hepatitis E virus in US blood donor samples using commercial assays.

Authors:  Mohammad Zafrullah; Xiugen Zhang; Coleen Tran; Megan Nguyen; Saleem Kamili; Michael A Purdy; Susan L Stramer
Journal:  Transfusion       Date:  2018-03-09       Impact factor: 3.157

4.  Prevalence of Hepatitis E Virus in Populations of Wild Animals in Comparison with Animals Bred in Game Enclosures.

Authors:  Monika Kubankova; Petr Kralik; Jiri Lamka; Vladimir Zakovcik; Marek Dolanský; Petra Vasickova
Journal:  Food Environ Virol       Date:  2015-03-15       Impact factor: 2.778

5.  Epidemiology of HEV in the Mediterranean basin: 10-year prevalence in Italy.

Authors:  Simone Lanini; Anna Rosa Garbuglia; Daniele Lapa; Vincenzo Puro; Assunta Navarra; Catia Pergola; Giuseppe Ippolito; Maria Rosaria Capobianchi
Journal:  BMJ Open       Date:  2015-07-14       Impact factor: 2.692

Review 6.  Epidemiology of Hepatitis E Virus in European Countries.

Authors:  Daniele Lapa; Maria Rosaria Capobianchi; Anna Rosa Garbuglia
Journal:  Int J Mol Sci       Date:  2015-10-27       Impact factor: 5.923

Review 7.  Hepatitis E Virus in Industrialized Countries: The Silent Threat.

Authors:  Pilar Clemente-Casares; Carlota Ramos-Romero; Eugenio Ramirez-Gonzalez; Antonio Mas
Journal:  Biomed Res Int       Date:  2016-12-14       Impact factor: 3.411

8.  Hepatitis E and Allogeneic Hematopoietic Stem Cell Transplantation: A French Nationwide SFGM-TC Retrospective Study.

Authors:  Aliénor Xhaard; Anne-Marie Roque-Afonso; Vincent Mallet; Patricia Ribaud; Stéphanie Nguyen-Quoc; Pierre-Simon Rohrlich; Reza Tabrizi; Johanna Konopacki; Séverine Lissandre; Florence Abravanel; Régis Peffault de Latour; Anne Huynh
Journal:  Viruses       Date:  2019-07-05       Impact factor: 5.048

9.  Hepatitis E virus infection in Europe: surveillance and descriptive epidemiology of confirmed cases, 2005 to 2015.

Authors:  Esther J Aspinall; Elisabeth Couturier; Mirko Faber; Bengü Said; Samreen Ijaz; Lara Tavoschi; Johanna Takkinen; Cornelia Adlhoch
Journal:  Euro Surveill       Date:  2017-06-29

10.  Clinical Outcomes and Prevalence of Hepatitis E Virus (HEV) Among Non-A-C Hepatitis Patients in Egypt.

Authors:  Ibrahim M Sayed; Mohamed A El-Mokhtar; Mahmoud Abdel Rahman Mahmoud; Amal A Elkhawaga; Shereen Gaber; Nermien H Seddek; Lobna Abdel-Wahid; Ahmed M Ashmawy; Enas Ahmed Reda Alkareemy
Journal:  Infect Drug Resist       Date:  2021-01-12       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.